Trial Details
RECRUITINGBasic Information
| Clinical ID | c2620 |
|---|---|
| Identifier | NCT03219359 |
| Trial Title | Autologous Stem Cell Transplant for Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | PROCEDURE: Autologous stem cell transplant|DRUG: Cyclophosphamide|DRUG: Cyclophosphamide|DRUG: Thymoglobulin|DRUG: Methylprednisolone|DRUG: Vedolizumab |
Participant Information
| Sponsor | Aaron Etra |
|---|---|
| City | Icahn School of Medicine at Mount Sinai |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-02-22 |
|---|---|
| Primary Completion Date | 2028-10 |
| Completion Date | 2028-10 |